insights_auto
Why is ANTX down 5,98%?
Dive Deeperchevron_right
ANTX:NASDAQ
AN2 Therapeutics Inc
4,40 USD
arrow_downward
-5,98%(-0,28) 1D
4,48 USD
arrow_upward
+1,82% (+0,080)bedtimeAfter hours
Closed: 9-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANTX...
Open
4,65 USD
High
4,67 USD
Low
4,26 USD
Mkt. cap
166,04 млн
Avg. vol.
264,57 миң
Volume
442,13 миң
52-wk high
7,19 USD
52-wk low
1,00 USD
EPS
-1,07 USD
Beta
-0,98
Shares outstanding
37,74 млн
No. of employees
21
Open
4,65 USD
High
4,67 USD
Low
4,26 USD
Mkt. cap
166,04 млн
Avg. vol.
264,57 миң
Volume
442,13 миң
52-wk high
7,19 USD
52-wk low
1,00 USD
EPS
-1,07 USD
Beta
-0,98
Shares outstanding
37,74 млн
No. of employees
21
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 күн мурун
AN2 Therapeutics (ANTX) Falls 9.63% to $5.07, Testing Key Support - Rating Change
https://www.dars.gov.et/
·
1 апта мурун
ANTX Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.66% - Trough Earnings Signal
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersМенло Парк, Калифорния, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitean2therapeutics.com